Berita Kesehatan
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Rabu, 19 Feb 2020 16:02:23

Camus Nimmo, James Millard, Kayleen Brien, Sashen Moodley, Lucy van Dorp, Keeren Lutchminarain, Allison Wolf, Alison D. Grant, Francois Balloux, Alexander S. Pym, Nesri Padayatchi, Max O'Donnell

European Respiratory Journal 2020; DOI: 10.1183/13993003.02383-2019

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr Nimmo reports grants from Wellcome Trust, during the conduct of the study.

Conflict of interest: Dr Millard reports grants from Wellcome Trust, during the conduct of the study.

Conflict of interest: Dr Brien has nothing to disclose.

Conflict of interest: Dr Moodley has nothing to disclose.

Conflict of interest: Dr van Dorp has nothing to disclose.

Conflict of interest: Dr Lutchminarain has nothing to disclose.

Conflict of interest: Dr Wolf reports grants from National Institutes of Health National Institute of Allergy and Infectious Diseases, during the conduct of the study.

Conflict of interest: Dr Grant has nothing to disclose.

Conflict of interest: Dr Balloux has nothing to disclose.

Conflict of interest: Dr Pym reports personal fees from Janssen Pharmaceutica, outside the submitted work.

Conflict of interest: Dr PADAYATCHI has nothing to disclose.

Conflict of interest: Dr O'Donnell has nothing to disclose.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received November 28, 2019.
  • Accepted February 6, 2020.